Clinical Trials on Progressive Colorectal Carcinoma in Belgium

Total 1219 results

Groupe Regional d'Etudes du Cancer Colorectal

Unknown

Combination Chemotherapy in Treating Patients With Colon Cancer

Colorectal Cancer

Belgium
University Hospital, Ghent

Completed

The Accuracy of Human Endoscopic Detection of Submucosal Invasive Cancer in Colorectal Polyps

Colorectal Polyp

Belgium
UCB Biopharma SRL

Completed

A Study to Test the Safety and Tolerability of UCB0107 in Study Participants With Progressive Supranuclear Palsy (PSP)

Progressive Supranuclear Palsy

Belgium, Germany, Spain, United Kingdom
Jessa Hospital

Completed

Comparison of the Clavien-Dindo and Comprehensive Complication Index

Colorectal Disorders | Complication of Surgical Procedure | Clavien Dindo | Comprehensive Complication Index

Belgium
GSO Global Clinical Research BV
Karyopharm Therapeutics Inc

Terminated

Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer (SENTINEL)

Colorectal Neoplasm

Germany, Belgium
Hoffmann-La Roche

Completed

A Dose-finding Study of RO5323441 in Patients With Metastatic Treatment-Refractory Colorectal or Ovarian Cancer

Colorectal Cancer, Ovarian Cancer

Belgium, Spain, United Kingdom
KU Leuven
Kom Op Tegen Kanker

Enrolling by invitation

Breakthrough Improvement Collaborative for ColoRectal Cancer (BIC4CRC) (BIC4CRC)

Colorectal Cancer

Belgium
University of Liege

Completed

Tolerance of Early Postoperative Mobilization and Ambulation (MOBTOL)

Colorectal Surgery | Bariatric Surgery | Ambulation Difficulty

Belgium
EuMelaReg gGmbH

Recruiting

Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients With Advanced NMSC

Basal Cell Carcinoma | Cutaneous Squamous Cell Carcinoma

Belgium
Celyad Oncology SA

Recruiting

alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells (alloSHRINK)

Unresectable Metastatic Colorectal Cancer

Belgium, United States
Cliniques universitaires Saint-Luc- Université...

Recruiting

Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck. (HN1901)

Oropharynx Squamous Cell Carcinoma | Oral Cavity Squamous Cell Carcinoma | Hypopharynx Squamous Cell Carcinoma | Larynx Squamous Cell Carcinoma

Belgium
Eli Lilly and Company

Completed

Study of IMC-11F8 in Participants With Colorectal Cancer

Metastatic Colorectal Cancer

Spain, Belgium
UCB Biopharma SRL

Active, not recruiting

A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy

Progressive Supranuclear Palsy

Belgium, Germany, Spain, United Kingdom
University Hospital, Antwerp
Amgen

Unknown

lead-in FOLICOLOR Trial: Following Therapy Response Through Liquid Biopsy in Metastatic Colorectal Cancer Patients

Metastatic Colorectal Cancer

Belgium
Celyad Oncology SA
Merck Sharp & Dohme LLC

Recruiting

Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer

Unresectable Metastatic Colorectal Cancer

Belgium, United States
Salubris Biotherapeutics Inc

Recruiting

Study of JK08 in Patients With Unresectable Locally Advanced or Metastatic Cancer

Melanoma | Clear Cell Renal Cell Carcinoma | Cancer | Hepatocellular Carcinoma | Colorectal Cancer | Pancreatic Adenocarcinoma | Gastric Adenocarcinoma | Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | Advanced Solid Tumor | Epithelial Ovarian Cancer | Non-small Cell... and other conditions

Belgium, Spain
Cliniques universitaires Saint-Luc- Université...

Completed

A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy

Transitional Cell Carcinoma

Belgium
Cliniques universitaires Saint-Luc- Université...
Merck Sharp & Dohme LLC

Completed

Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study (ECHO)

Time to Progression

Belgium
Ottawa Hospital Research Institute

Completed

Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal Cancer (PERIOP-01)

Adenocarcinoma of the Colon

Canada, France, Belgium
Universitair Ziekenhuis Brussel

Recruiting

Functional Status and Quality of Life in Older Patients Undergoing Robotic Surgery for Colorectal Cancer (ROBO-G)

Quality of Life | Colorectal Surgery | Geriatric Assessment

Belgium
Universitaire Ziekenhuizen KU Leuven
AstraZeneca; European Organisation for Research and Treatment of Cancer - EORTC and other collaborators

Active, not recruiting

Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity (DUTRELASCO)

Oral Cavity Squamous Cell Carcinoma

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Prehabilitation in Colorectal Cancer

Colon Cancer

Belgium
Jules Bordet Institute
University Hospital, Ghent

Completed

Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only

Colorectal Neoplasm | Secondary Malignant Neoplasm of Liver

Belgium
University Hospital, Ghent

Completed

Inception, Validation and Clinical Utility of a Score to Assess the Completeness of Caecal Visualisation

Colorectal Cancer | Colonic Polyp

Belgium
University Hospital, Ghent

Completed

Adaptive, Image-guided, Intensity-modulated Radiotherapy for Head and Neck Cancer in the Reduced Volumes of Elective Neck

Primary Non-operated Squamous Cell Carcinoma of Oral Cavity | Primary Non-operated Squamous Cell Carcinoma of Oropharynx | Primary Non-operated Squamous Cell Carcinoma of Hypopharynx | Primary Non-operated Squamous Cell Carcinoma of Larynx

Belgium
Jules Bordet Institute

Completed

Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers (MOMENTUM1)

Metastatic Colorectal Cancers | Metastatic Gastric Cancers | Metastatic Oesophageal Cancers | Metastatic Pancreatic Cancers | Metastatic Biliary Cancers | Metastatic Breast Cancers

Belgium
Mirum Pharmaceuticals, Inc.

Active, not recruiting

An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC)

Progressive Familial Intrahepatic Cholestasis (PFIC)

United States, Argentina, France, Singapore, United Kingdom, Belgium, Turkey, Austria, Brazil, Canada, Colombia, Germany, Italy, Lebanon, Mexico, Poland
Cliniques universitaires Saint-Luc- Université...

Completed

Profile of Plasma Growth Factors Before and After Head and Neck Oncological or Non-oncological Surgery (HNSCC)

Surgery | Head and Neck Squamous Cell Carcinoma | Growth Factor

Belgium
Cliniques universitaires Saint-Luc- Université...
Grand Hôpital de Charleroi

Terminated

Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors

Metastatic Colorectal Cancer

Belgium
Mirum Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC) (MARCH-PFIC)

Progressive Familial Intrahepatic Cholestasis (PFIC)

Italy, United States, Argentina, France, Singapore, United Kingdom, Austria, Brazil, Mexico, Lebanon, Germany, Turkey, Poland, Belgium, Canada, Colombia, Hungary
University Hospital, Ghent

Completed

Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial

Bowen's Disease | Superficial Basal Cell Carcinoma

Belgium
Cliniques universitaires Saint-Luc- Université...

Recruiting

Patient-derived Xenograft Models of Tumor From Patients With Head and Neck Cancer (UCL-Xenog)

Squamous Cell Carcinoma of the Head and Neck

Belgium
University Hospital, Ghent

Completed

Comparison of Adaptive Dose Painting by Numbers With Standard Radiotherapy for Head and Neck Cancer. (C-ART-2)

Primary Non-operated Squamous Cell Carcinoma of Oral Cavity | Primary Non-operated Squamous Cell Carcinoma of Oropharynx | Primary Non-operated Squamous Cell Carcinoma of Hypopharynx | Primary Non-operated Squamous Cell Carcinoma of Larynx

Belgium
Universitaire Ziekenhuizen KU Leuven
Flemish League Against Cancer

Terminated

Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma

Head and Neck Cancer

Belgium
University Hospital, Ghent
Ipsen

Completed

Influence of Somatuline Autogel 120mg on Post-operative Drainage After Total Mesorectum Excision for Rectumcarcinoma

Rectal Carcinoma

Belgium
AZ-VUB
Sanofi

Unknown

Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

Non-Small-Cell Lung Carcinoma

Belgium
GamaMabs Pharma

Completed

Study for Evaluation of Murlentamab (GM102) Anti-tumoral Activity in Colorectal Cancers

Colorectal Cancer

Belgium, Czechia
Jules Bordet Institute
Innate Pharma

Withdrawn

Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CA (ARTEMIS-Eso)

Adenocarcinoma of the Gastroesophageal Junction | Squamous Cell Carcinoma of the Esophagus | Adenocarcinoma of the Esophagus

Belgium
Jules Bordet Institute

Active, not recruiting

Prospective Pilot Study Evaluating Dental Side Effects of Radiotherapy on Subjects Treated for Head and Neck Cancer (StomRay)

Head and Neck Squamous Cell Carcinoma

Belgium
University Hospital, Ghent

Terminated

Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC) (TRACE)

Hepatocellular Carcinoma

Belgium
Cliniques universitaires Saint-Luc- Université...
University Hospital, Rouen; University Hospital, Montpellier; Central Hospital... and other collaborators

Unknown

Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma (pet)

Head and Neck Squamous Cell Carcinoma

Belgium
Elizabeth Van Eycken
Flemish League Against Cancer

Completed

Quality of Life in Colorectal (ex-)Cancer Patients, Based on the Belgian Cancer Registry. (QOLColorect)

Quality of Life | Colorectal Cancer

Belgium
Niti Medical Technologies Ltd.

Completed

End-to-End Compression Anastomosis for Left-sided Colectomy Endo-CAR Study

Colorectal Cancer | Diverticulitis

Belgium
Centre Hospitalier Universitaire Dinant Godinne...

Not yet recruiting

Prognostic Impact of Tumor Growth Velocity in Head and Neck Squamous Cell Carcinoma Treated by Radio(Chemo)Therapy (TGV-PI)

Head and Neck Squamous Cell Carcinoma | Tumor Growth

Belgium
AZ-VUB

Unknown

Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma.

Non Small Cell Lung Carcinoma

Belgium
Centre Hospitalier Universitaire Dinant Godinne...

Recruiting

Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance Technologies (SUPRA-QoL)

Supraglottic Squamous Cell Carcinoma | Early Stage (T1-T2, N0-N1,M0)

Belgium
Symphogen A/S

Completed

Sym004 in Patients With Advanced Solid Tumors

Metastatic Colorectal Cancer

Spain, United States, Belgium
PharmaMar

Completed

Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC).

Metastatic Colorectal Cancer | Pancreatic Cancer | Metastatic Breast Cancer

Spain, Belgium
Universitair Ziekenhuis Brussel

Unknown

Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy System

Non-Small Cell Lung Carcinoma

Belgium
Universitair Ziekenhuis Brussel
Janssen, LP

Completed

Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC) (DECIT)

Colorectal Cancer | Liver Metastasis

Belgium

Clinical Trials on Progressive Colorectal Carcinoma in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations